Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research di Ming Wang (8809334)

Soggetti:

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH S... di Subhamoy Chakraborty (16648124)

Soggetti:

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients di Cloud P. Paweletz (14960112)

Soggetti:

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa... di Subhamoy Chakraborty (16648124)

Soggetti:

Supplemental Fig. 2 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer di Noura J. Choudhury (15029759)

Soggetti:

Supplemental Fig. 3 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer di Noura J. Choudhury (15029759)

Soggetti:

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa... di Subhamoy Chakraborty (16648124)

Soggetti:

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa... di Subhamoy Chakraborty (16648124)

Soggetti:

Supplemental Fig. 1 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer di Noura J. Choudhury (15029759)

Soggetti:

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma di Lijun Yao (15292963)

Soggetti:

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... di Stephanie Lheureux (16797697)

Soggetti:

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using ²H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism di Friederike Hesse (14958870)

Soggetti:

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using ²H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism di Friederike Hesse (14958870)

Soggetti:

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using ²H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism di Friederike Hesse (14958870)

Soggetti:

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using ²H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism di Friederike Hesse (14958870)

Soggetti: